Speaker Profile
Executive Director, Merck
Biography
Reena Philip, Ph.D., is Executive Director for Companion Diagnostics and In Vitro Diagnostics at Merck, where she brings extensive regulatory-science experience to the co-development of targeted medicines and the tests used to select patients for treatment. Before joining industry, she held senior positions at the U.S. Food and Drug Administration, including Associate Director for Biomarkers and Precision Oncology in the FDA Oncology Center of Excellence and leadership roles in the regulation of molecular diagnostic tests. At FDA, she worked across drug and device centers on companion diagnostics, genomic biomarkers, complex molecular signatures, liquid biopsy, and other technologies central to precision oncology. She contributed to regulatory policy and guidance addressing the coordinated development of therapeutics and diagnostic devices. Dr. Philip earned her Ph.D. in molecular biology from the University of Illinois Urbana-Champaign. Her work focuses on aligning biomarker strategy, analytical and clinical validation, regulatory requirements, and therapeutic development so that precision medicines can reach the patients most likely to benefit.
Talk
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
